Flow Cytometry Analysis of Cell Cycle and Specific Cell Synchronization with Butyrate

Author(s):  
Cong-Jun Li
Cells ◽  
2018 ◽  
Vol 7 (11) ◽  
pp. 199 ◽  
Author(s):  
Xiaolan Chen ◽  
Hongjia Ouyang ◽  
Zhijun Wang ◽  
Biao Chen ◽  
Qinghua Nie

It is well known that fibroblast growth factor receptor 2 (FGFR2) interacts with its ligand of fibroblast growth factor (FGF) therefore exerting biological functions on cell proliferation and differentiation. In this study, we first reported that the FGFR2 gene could generate a circular RNA of circFGFR2, which regulates skeletal muscle development by sponging miRNA. In our previous study of circular RNA sequencing, we found that circFGFR2, generated by exon 3–6 of FGFR2 gene, differentially expressed during chicken embryo skeletal muscle development. The purpose of this study was to reveal the real mechanism of how circFGFR2 affects skeletal muscle development in chicken. In this study, cell proliferation was analyzed by both flow cytometry analysis of the cell cycle and 5-ethynyl-2′-deoxyuridine (EdU) assays. Cell differentiation was determined by analysis of the expression of the differentiation marker gene and Myosin heavy chain (MyHC) immunofluorescence. The results of flow cytometry analysis of the cell cycle and EdU assays showed that, overexpression of circFGFR2 accelerated the proliferation of myoblast and QM-7 cells, whereas knockdown of circFGFR2 with siRNA reduced the proliferation of both cells. Meanwhile, overexpression of circFGFR2 accelerated the expression of myogenic differentiation 1 (MYOD), myogenin (MYOG) and the formation of myotubes, and knockdown of circFGFR2 showed contrary effects in myoblasts. Results of luciferase reporter assay and biotin-coupled miRNA pull down assay further showed that circFGFR2 could directly target two binding sites of miR-133a-5p and one binding site of miR-29b-1-5p, and further inhibited the expression and activity of these two miRNAs. In addition, we demonstrated that both miR-133a-5p and miR-29b-1-5p inhibited myoblast proliferation and differentiation, while circFGFR2 could eliminate the inhibition effects of the two miRNAs as indicated by rescue experiments. Altogether, our data revealed that a novel circular RNA of circFGFR2 could promote skeletal muscle proliferation and differentiation by sponging miR-133a-5p and miR-29b-1-5p.


2006 ◽  
Vol 18 (2) ◽  
pp. 209
Author(s):  
M. A. Ramírez ◽  
E. Pericuesta ◽  
M. Pérez-Crespo ◽  
R. Fernández-González ◽  
P. N. Moreira ◽  
...  

Normally the majority of mammalian cells, including murine embryonic stem (mES) cells, are immersed in a low oxygen environment (hypoxia); however, mES are generally cultured in an atmosphere containing 21% O2 (normoxia). Such conditions may not be the most appropriate for mES propagation. We have tested the effects of hypoxia and culture on either feeder fibroblasts or gelatin substrate on mES cell growth and spontaneous differentiation. Two ES cell lines (R1 129/Sv from the laboratory of A. Nagy and MAR B6D2 F1 generated in our laboratory) were cultured under two different oxygen tensions (5 and 21%), and on two different substrates, 0.1% gelatin or murine embryonic fibroblasts (mEF). Cell cycle, cell proliferation, mRNA expression of pluripotency and differentiation markers, as well as spontaneous differentiation to cardiomyocytes, were monitored. For cell proliferation measurements, mES after 7 days of culture at the different conditions were labeled with 5-(and-6)-carboxyfluorescein diacetate succinimidyl ester, and cultured for up to three more days. Cells were then harvested for flow cytometry analysis every 24 h after labeling (Cell TraceTM CFSE Cell Proliferation Kit; Molecular Probes, Inc., Eugene, OR, USA). For cell cycle analysis, cells grown on mEF under the two different oxygen tensions were fixed after 10 days of culture, and then stained with propidium iodide/Triton-X-100 for flow cytometry analysis (Current Protocols in Cytometry, Chap. 7, 2001). The spontaneous differentiation of embryoid bodies [formed by ES cells in the absence of leukemia inhibitory factor (LIF)] to cardiomyocytes was also monitored. For mRNA expression of pluripotency (Nanog, Oct-3/4, Rex1, GENESIS, FGFR-4, TERF1, Cx43, and GLUT1) and differentiation markers (GATA4, GATA2, AFP, Msx-1, Brachyury, and Myf5), RT-PCR analysis was performed on mES cells from Day 0 to Day 10. Under hypoxia conditions, the proliferation of both types of mES cells was greater than under normoxia, independent of substrate used, and a higher number of apoptotic cells was detected. Moreover, only under normoxia conditions did mES cells lose the expression of pluripotency markers GENESIS and GLUT1. In addition, under lower oxygen tension, the rate of differentiation to beating cardiomyocytes was significantly lower on the feeder layer than that under normoxia (11.9% vs. 28.1%; P = 0.012). The feeder layer supported significantly higher cardiomyocyte formation when compared to 0.1% gelatin at 21% O2 (28.1% vs. 8.3%; P < 0.001). Our results show that normoxia may not be the most appropriate condition for mES cell propagation and that hypoxic culture may be necessary to maintain full pluripotency of mES cells.


Blood ◽  
2012 ◽  
Vol 120 (21) ◽  
pp. 329-329
Author(s):  
Sathisha Upparahallivenkateshaiah ◽  
Khan Sharmin ◽  
Ling Wen ◽  
Rakesh Bam ◽  
Xin Li ◽  
...  

Abstract Abstract 329 Accumulating evidence indicate that cellular metabolism and bi-products also play important roles in signaling associated with tumor cell proliferation, cell cycle, survival and drug resistance. The overall goal of the study was to molecularly characterize MM cells grown in the supportive bone marrow (BM) of clinically relevant SCID-hu or SCID-rab models. MM cells from 22 patients were engrafted in experimental animals. Following establishment of the disease as determined by increased production of circulating human immunoglobulins over a period of 2–4 months, MM cells were isolated from the implanted bones and subjected to global gene expression profile (GEP). Based on stringent criteria (e.g. p<0.05, >2 folds) we identified commonly overexpressed or underexpressed genes in post-engrafted MM cells compared to pre-engrafted cells from the same patients. Among the top upregulated genes we identified several factors associated with lipid metabolism including FABP5 (fatty acid-binding protein 5), SCD (stearoyl CoA desaturase 1), FADS1 (fatty acid desaturase 1) and SLC27A5 (a fatty acid transporter). Clinical GEP data of newly diagnosed patients from Total Therapy program at our institute revealed upregulation of these genes in high risk patients. We further sought to unravel the role of SCD in MM since it has been previously implicated in tumorigenesis and specific inhibitors are being developed for clinical use. SCD (encodes SCD1), is a rate-limiting enzyme responsible for synthesis of monounsaturated fatty acids. We hypothesized that while nutrient unsaturated fatty acids sufficiently satisfy requirement of most normal cells, growing MM cells demand higher content of these lipids for formation of new membrane phospholipids and immediate energy; therefore, inhibiting SCD1 may suppress MM cell survival and proliferation. Small-molecule inhibitor of SCD1 (BioVision) suppressed growth of 5 MM lines dose dependently; 72 hours IC50 ranged between 1μM (p<0.0006) and 2.5 μM (p<0.0001). At 1 μM the SCD1 inhibitor reduced MM cell proliferation by 70±4% (p<0.002) using thymidine incorporation assay and increased number of apoptotic MM cells from 10±1% in control cells to 27±8% in SCD1 inhibitor-treated cells (p<0.03), using annexin V/PI flow cytometry analysis. This inhibitor also disrupted cell cycle progression in MM cell lines as determined by flow cytometry analysis of DNA content. The Akt/mTOR and AMPK pathways, albeit opposing functions, are known central integrators of cellular metabolism and proliferation signaling. SCD1 inhibitor reduced phosphorylated AKT and increased phosphorylated AMPK in MM cells assessed by Western Blot. For in vivo experiments in SCID-rab mice, SCD1 inhibitor was constantly administered (1.25 μg/hour) by osmotic pumps directly connected to the implanted bones that had been engrafted with luciferase-expressing H929 MM cells (6 mice/group). SCD1 inhibitor suppressed MM growth by 60% (p<0.01) assessed by live-animal imaging and measurement of circulating levels of human immunoglobulins in mice sera. These findings suggest that intracellular modulators of lipid metabolism such as SCD1 are induced in MM cells by the supportive BM and mediate signals linking cellular metabolism, survival and proliferation. Disclosures: No relevant conflicts of interest to declare.


2014 ◽  
Vol 50 (5) ◽  
pp. 453-463 ◽  
Author(s):  
Israel Torres-Castro ◽  
César N. Cortés-Rubio ◽  
Guadalupe Sandoval ◽  
Edmundo Lamoyi ◽  
Carlos Larralde ◽  
...  

1992 ◽  
Vol 21 (1) ◽  
pp. 39-42 ◽  
Author(s):  
G. Lizard ◽  
P. Roignot ◽  
L. Dusserre-Guion ◽  
F. Morlevat ◽  
D. Michiels-Marzais ◽  
...  

10.4081/838 ◽  
2009 ◽  
Vol 47 (4) ◽  
pp. 289 ◽  
Author(s):  
G Mazzini ◽  
C Ferrari ◽  
E Erba

The discrimination of live/dead cells as well as the detection of apoptosis is a frequent need in many areas of experimental biology. Cell proliferation is linked to apoptosis and controlled by several genes. During the cell life, specific events can stimulate proliferation while others may trigger the apoptotic pathway. Very few methods (i.e. TUNEL) are now available for studies aimed at correlation between apoptosis and proliferation. Therefore, there is interest in developing new methodological approaches that are able to correlate apoptosis to the cell cycle phases. Recently new approaches have been proposed to detect and enumerate apoptotic cells by flow cytometry. Among these, the most established and applied are those based on the cell membrane modifications induced in the early phases of the apoptotic process. The dye pair Hoechst 33342 (HO) and Propidium Iodide (PI), thanks to their peculiar characteristics to be respectively permeable and impermeable to the intact cell membrane, seems to be very useful. Unfortunately the spectral interaction of these dyes generates a consistent “energy transfer” from HO to PI. The co-presence of the dyes in a nucleus results in a modification in the intensity of both the emitted fluorescences. In order to designate the damaged cells (red fluorescence) to the specific cell cycle phases (blue fluorescence), we have tested different staining protocols aimed to minimize the interference of these dyes as much as possible. In cell culture models, we are able to detect serum-starved apoptotic cells as well as to designate their exact location in the cell cycle phases using a very low PI concentration. Using a Partec PAS flow cytometer equipped with HBO lamp and argon ion laser, a double UV/blue excitation has been performed. This analytical approach is able to discriminate live blue cells from the damaged (blue-red) ones even at 0.05 ?g/mL PI. The same instrumental setting allows performing other multi-colour analyses including AnnexinV-FITC as well as the possibility to make a correlated analysis to phenotype markers.


2021 ◽  
Vol 1 ◽  
Author(s):  
David W. James ◽  
Andrew Filby ◽  
M. Rowan Brown ◽  
Huw D. Summers ◽  
Lewis W. Francis ◽  
...  

Many chemotherapeutic drugs target cell processes in specific cell cycle phases. Determining the specific phases targeted is key to understanding drug mechanism of action and efficacy against specific cancer types. Flow cytometry experiments, combined with cell cycle phase and division round specific staining, can be used to quantify the current cell cycle phase and number of mitotic events of each cell within a population. However, quantification of cell interphase times and the efficacy of cytotoxic drugs targeting specific cell cycle phases cannot be determined directly. We present a data driven computational cell population model for interpreting experimental results, where in-silico populations are initialized to match observable results from experimental populations. A two-stage approach is used to determine the efficacy of cytotoxic drugs in blocking cell-cycle phase transitions. In the first stage, our model is fitted to experimental multi-parameter flow cytometry results from untreated cell populations to identify parameters defining probability density functions for phase transitions. In the second stage, we introduce a blocking routine to the model which blocks a percentage of attempted transitions between cell-cycle phases due to therapeutic treatment. The resulting model closely matches the percentage of cells from experiment in each cell-cycle phase and division round. From untreated cell populations, interphase and intermitotic times can be inferred. We then identify the specific cell-cycle phases that cytotoxic compounds target and quantify the percentages of cell transitions that are blocked compared with the untreated population, which will lead to improved understanding of drug efficacy and mechanism of action.


2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Jia-Lu Zheng ◽  
Shuang-Shuang Wang ◽  
Ke-Ping Shen ◽  
Lei Chen ◽  
Xiao Peng ◽  
...  

Abstract Background Ursolic acid (UA) is an anti-cancer herbal compound. In the present study, we observed the effects of UA on anchorage-dependent and -independent growth of human colorectal cancer (CRC) RKO cells. Methods RKO cells were cultured in conventional and detached condition and treated with UA. Cell viability was evaluated by CCK-8 assay. Cell cycle was analyzed by flow cytometry. Apoptosis was identified by Hoechst 33258 staining and flow cytometry analysis. Activities of caspases were measured by commercial kits. Reactive oxygen species (ROS) was recognized by DCFH-DA fluorescent staining. Anoikis was identified by EthD-1 fluorescent staining and flow cytometry analysis. Expression and phosphorylation of proteins were analyzed by western blot. Results UA inhibited RKO cell viability in both a dose- and time-dependent manner. UA arrested the cell cycle at the G0/G1 phase, and induced caspase-dependent apoptosis. UA inhibited Bcl-2 expression and increased Bax expression. In addition, UA up-regulated the level of ROS that contributed to UA activated caspase-3, − 8 and − 9, and induced apoptosis. Furthermore, UA inhibited cell growth in a detached condition and induced anoikis in RKO cells that was accompanied by dampened phosphorylation of FAK, PI3K and AKT. UA also inhibited epithelial-mesenchymal transition (EMT) as indicated by the down-regulation of N-Cad expression and up-regulation of E-Cad expression. Conclusions UA induced caspase-dependent apoptosis, and FAK/PI3K/AKT singling and EMT related anoikis in RKO cells. UA was an effective anti-cancer compound against both anchorage-dependent and -independent growth of RKO cells.


Sign in / Sign up

Export Citation Format

Share Document